Drugs / TJAOA102
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05522621 | Oct 2022 → Oct 2024 | — | Tongji Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TJAOA102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05522621 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “the Chinese herbal compound TJAOA102” NCT05522621 ↗ |
| Route | Oral | “take orally twice a day” NCT05522621 ↗ |